What smart money is saying about ASGN
ASGN
No fund has written a full thesis on ASGN in our archive, but 2 fund letters report a position in it — most recently Clearbridge Small Cap Strategy in September 2025.
Get an email when a fund writes about it
2
Reported positions
0
Bought
1
Sold
2
Letters
Position history
Between Q1 2025 and Q3 2025, 2 fund letters reported a position in ASGN — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2025 | 1 | 0 | 1 | 0 |
| Q1 2025 | 1 | 0 | 0 | 0 |
Fund activity · 2 positions · 1 move
- September 2025
“We exited positions in GoodRx and Ultragenyx Pharmaceutical in the health care sector, Oxford Industries in the consumer discretionary sector, Anterix in the communication services sector, Wabash National in the industrials sector, ASGN in the IT sector and LXP Industrial Trust in the real estate sector.”
ASGN - March 2025
“The business services sector was another area of weakness, with ASGN Incorporated, First Advantage Corp., and Montrose Environmental Group Inc. detracting from performance.”
ASGN
Read the letters behind these ASGN positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger